|
HEATR3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.620600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.215800E-02 |
| Normal-vs-Stage2 |
9.456400E-02 |
| Normal-vs-Stage3 |
4.384400E-03 |
| Normal-vs-Stage4 |
1.065630E-01 |
| Stage1-vs-Stage2 |
6.773000E-01 |
| Stage1-vs-Stage3 |
1.766190E-01 |
| Stage1-vs-Stage4 |
8.609200E-01 |
| Stage2-vs-Stage3 |
6.129400E-01 |
| Stage2-vs-Stage4 |
8.548400E-01 |
| Stage3-vs-Stage4 |
4.335400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.475500E-03 |
| Normal-vs-AfricanAmerican |
1.194950E-01 |
| Normal-vs-Asian |
3.789600E-01 |
| Caucasian-vs-AfricanAmerican |
9.642000E-01 |
| Caucasian-vs-Asian |
1.553370E-01 |
| AfricanAmerican-vs-Asian |
2.351000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.982260E-03 |
| Normal-vs-Female |
1.519990E-01 |
| Male-vs-Female |
8.137900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.395400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.108000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.236000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.734200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.542600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.657200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.831400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.960200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.870200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.977200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.644000E-01 |
| Normal-vs-Grade 2 |
3.580100E-02 |
| Normal-vs-Grade 3 |
1.396270E-03 |
| Normal-vs-Grade 4 |
2.220800E-01 |
| Grade 1-vs-Grade 2 |
7.412200E-02 |
| Grade 1-vs-Grade 3 |
2.141800E-02 |
| Grade 1-vs-Grade 4 |
1.707170E-01 |
| Grade 2-vs-Grade 3 |
1.998410E-01 |
| Grade 2-vs-Grade 4 |
8.352000E-01 |
| Grade 3-vs-Grade 4 |
3.231600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.405930E-02 |
| Normal-vs-ccB subtype |
8.557800E-02 |
| ccA subtype-vs-ccB subtype |
5.410400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.010400E-02 |
| Normal-vs-N1 |
5.303400E-01 |
| N0-vs-N1 |
2.535200E-01 |
|
|
